Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 50018320
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194364(4-(4-cinnamamidobutyl)-N-(3,4-dichlorophenyl)-1,4-...)
Affinity DataIC50: 170nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194380(N-(3,4-dichlorophenyl)-4-(3-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 320nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194365(N-(3,4-dichlorophenyl)-4-(6-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 440nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194374(TCMDC-135759 | N-(3,4-dichlorophenyl)-4-(5-(3-(3,4...)
Affinity DataIC50: 470nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194375(TCMDC-136124 | N-(3,4-dichlorophenyl)-1-(5-(3-(3,4...)
Affinity DataIC50: 630nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194376(N-(3,4-dichlorophenyl)-4-(4-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 710nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194370(TCMDC-135755 | N-(3-chloro-4-fluorophenyl)-4-(5-(3...)
Affinity DataIC50: 720nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194363(N-(3,4-dichlorophenyl)-4-(5-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 940nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194383(N-(3-chloro-4-fluorophenyl)-4-(5-(3-(3,4-dichlorop...)
Affinity DataIC50: 980nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194381(N-(3-chlorophenyl)-4-(5-(3-(3,4-dichlorophenyl)acr...)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194372(N-(4-chloro-3-(trifluoromethyl)phenyl)-4-(5-(3-(3,...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194367(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194363(N-(3,4-dichlorophenyl)-4-(5-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human liver GPa in absence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194369(TCMDC-135933 | N-(3,4-dichlorophenyl)-4-(6-(3-(3,4...)
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194368(TCMDC-135735 | N-(4-chloro-3-(trifluoromethyl)phen...)
Affinity DataIC50: 5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194377(N-(4-chlorophenyl)-4-(5-(3-(3,4-dichlorophenyl)acr...)
Affinity DataIC50: 5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194366(N-(3-chlorophenyl)-4-(5-(3-(3,4-dichlorophenyl)acr...)
Affinity DataIC50: 5.10E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194385(-N-(benzo[d][1,3]dioxol-5-yl)-4-(5-(3-(3,4-dichlor...)
Affinity DataIC50: 7.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194382(N-(3,4-dichlorophenyl)-4-(2-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 9.00E+4nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194371(TCMDC-135744 | 4-(5-(3-(3,4-dichlorophenyl)acrylam...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194373(N-(3,4-dichlorophenyl)-4-(2-(3-(3,4-dichlorophenyl...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194378(N-(4-chlorophenyl)-4-(5-(3-(3,4-dichlorophenyl)acr...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194379(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-(...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50194384(4-(5-(3-(3,4-dichlorophenyl)acrylamido)pentyl)-N-p...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human liver GPa in presence of glucoseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed